BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2405711)

  • 1. Direct visualization of effects of endothelin on the renal microvasculature.
    Loutzenhiser R; Epstein M; Hayashi K; Horton C
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F61-8. PubMed ID: 2405711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.
    Lanese DM; Conger JD
    J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of KCl-induced depolarization on afferent and efferent arterioles.
    Loutzenhiser R; Hayashi K; Epstein M
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F561-4. PubMed ID: 2552832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of endothelin effects by a chloride channel inhibitor, indanyloxyacetic acid.
    Takenaka T; Epstein M; Forster H; Landry DW; Iijima K; Goligorsky MS
    Am J Physiol; 1992 May; 262(5 Pt 2):F799-806. PubMed ID: 1317119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin.
    Madeddu P; Yang XP; Anania V; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F304-11. PubMed ID: 2201205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal microvascular effects of endothelin.
    Edwards RM; Trizna W; Ohlstein EH
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F217-21. PubMed ID: 2201203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal vasoconstriction by the endothelial cell-derived peptide endothelin in spontaneously hypertensive rats.
    Hirata Y; Matsuoka H; Kimura K; Fukui K; Hayakawa H; Suzuki E; Sugimoto T; Sugimoto T; Yanagisawa M; Masaki T
    Circ Res; 1989 Nov; 65(5):1370-9. PubMed ID: 2680150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative sensitivities of isolated rat renal arterioles to endothelin.
    Lanese DM; Yuan BH; McMurtry IF; Conger JD
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F894-9. PubMed ID: 1443178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the renal microvascular effects of angiotensin II antagonist, DuP 753: studies in isolated perfused hydronephrotic kidneys.
    Loutzenhiser R; Epstein M; Hayashi K; Takenaka T; Forster H
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):309S-314S. PubMed ID: 1854457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
    Loutzenhiser R; Hayashi K; Epstein M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):522-8. PubMed ID: 2969977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate effects of calcium antagonists on renal microcirculation.
    Hayashi K; Nagahama T; Oka K; Epstein M; Saruta T
    Hypertens Res; 1996 Mar; 19(1):31-6. PubMed ID: 8829821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of renal actions of atrial natriuretic peptide. Lack of effect of atrial natriuretic peptide on pressure-induced vasoconstriction.
    Hayashi K; Epstein M; Loutzenhiser R
    Circ Res; 1990 Jul; 67(1):1-10. PubMed ID: 2163775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats. Studies in the isolated perfused hydronephrotic kidney.
    Hayashi K; Epstein M; Loutzenhiser R
    Circ Res; 1989 Dec; 65(6):1475-84. PubMed ID: 2582584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin: a potent renal and systemic vasoconstrictor peptide.
    King AJ; Brenner BM; Anderson S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1051-8. PubMed ID: 2660593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of endothelin-1 on glomerular haemodynamics in the dog: lack of direct effects on glomerular ultrafiltration coefficient.
    Heller J; Kramer HJ; Horacek V
    Clin Sci (Lond); 1996 May; 90(5):385-91. PubMed ID: 8665776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine vasopressin interacts with thromboxane in hydronephrosis.
    Takenaka T; Forster H
    Am J Physiol; 1997 Jan; 272(1 Pt 2):F40-7. PubMed ID: 9039047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of a calcium antagonist against renal vasoconstriction induced by endothelin in the normotensive rat].
    Madeddu P; Pala F; Troffa C; Pinna Parpaglia P; Pazzola A; Soro A; Manunta P; Tonolo G; Melis MG; Demontis MP
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):671-8. PubMed ID: 2083061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
    Perico N; Dadan J; Gabanelli M; Remuzzi G
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1213-20. PubMed ID: 2138667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole.
    Hayashi K; Loutzenhiser R; Epstein M
    J Am Soc Nephrol; 1997 Jan; 8(1):25-31. PubMed ID: 9013445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II.
    Loutzenhiser R; Chilton L; Trottier G
    Am J Physiol; 1997 Aug; 273(2 Pt 2):F307-14. PubMed ID: 9277592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.